Highlights from the 6th SScWC 2020 E-Congress – slide kit
Nuove analisi dello studio clinico SENSCIS su SSc-ILD presentate al 6° SSc WC Congress, 2020
![]() |
Nel seguente slide kit sono riportate le principali analisi in ambito SSc-ILD presentate al Congresso Internazionale SScWC, 2020:
Disease course of progressive interstitial lung disease in systemic sclerosis: a 5-year follow-up from the EUSTAR database (Hoffmann-Vold AM)
Does doseadjustment affect decline in forced vital capacity in patients treated with nintedanib? (Mayes MD)
Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) (Khanna D)
Effect of nintedanib in patients with extensive and limited systemic sclerosis-associated ILD (Denton CP)
Effect of nintedanib on progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD) over 100 weeks (Assassi S)
ARTICOLI CORRELATI
![Card image Card image](/it/medaffairs/sites/default/files/2022-12/image_2.png)
Highlights from the 6th SScWC 2020 E-Congress – slide kit
![Card image Card image](/it/medaffairs/sites/default/files/2022-12/image_2.png)